“We’re thrilled to be able to share this news after a much-anticipated wait for FDA approval of the TOUCH® CMC 1 prosthesis. This is a huge opportunity for surgeons to treat patients with a unique procedure that has already been proven successful in Europe. We have a great team that is ready to get surgeons trained on this technology and we look forward to hearing stories of patients that were able to get back to enjoying their daily lives because of this treatment option,”